Episode

Episode 213: HIV PrEP Review

Podcast: Rio Bravo qWeek
Published: Feb 20, 2026
Duration seconds: 1215
Processing state: not_requested
Canonical source: https://rio-bravo-qweek.simplecast.com/episodes/episode-214-hiv-prep-review-qpVRqnzp
Audio: https://cdn.simplecast.com/media/audio/transcoded/3fc5af21-72c0-4090-b6f3-ffa15201221e/2669d47b-1a83-4e99-a326-10778e7c2687/episodes/audio/group/b107fb7d-904b-45d3-906b-6c24bdb0cd24/group-item/a2119d37-32d5-4607-8380-871f9b53858d/128_default_tc.mp3?aid=rss_feed&feed=l3pUv9I_
JSON: /v1/public/podcasts/rio-bravo-qweek-508053/episodes/episode-213-hiv-prep-review
Markdown: /podcast/rio-bravo-qweek-508053/episode-213-hiv-prep-review.md

Actions

POST https://stenobird.com/v1/public/podcasts/rio-bravo-qweek-508053/episodes/episode-213-hiv-prep-review/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/rio-bravo-qweek-508053/episode-213-hiv-prep-review.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Episode 213: HIV PrEP Review H. Nicole Magaña, medical student, reviews the history of PrEP and outlines the currently FDA-approved medications used for HIV prevention. Dr. Arreaza provides additional perspective on long-acting injectable options, including how quickly they begin to protect patients after initiation. Written by Nicole Magana, MSIV, American University of the Caribbean. Comments and edits by Hector Arreaza, MD.